title: Response to the paper entitled "dopamine mobilizes mesenchymal progenitor cells through D2-class receptors and their PI3K/AKT pathway" by Mirones, et al., 2014.
authors.affiliation: Department of Pathology, Ohio State University, Columbus, Ohio, USA; Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, Ohio, USA.
authors.forename: Sujit
authors.initials: S
authors.lastname: Basu
authors.forename: Partha Sarathi
authors.initials: PS
authors.lastname: Dasgupta
mesh_terms: D000818:Animals; D004298:Dopamine / Q000494:pharmacology*; D005260:Female; D006801:Humans; D059630:Mesenchymal Stem Cells / Q000166:cytology*; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism*; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism*
chemical_list: D019869:Phosphatidylinositol 3-Kinases; D051057:Proto-Oncogene Proteins c-akt; D004298:Dopamine
keywords: Dopamine D2 receptors; Endothelial progenitor cells; Mesenchymal stem cells; Mobilization